De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia
39: 1216 - 1225, 1998.
Coulter DL. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity [letter].
Lancet
1: 689, 1984.
Ater SB, et al. A developmental center population treated with VPA and L-carnitine. In: Update 1993: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals; 1993.
Dreifuss FE and Langer DH. Hepatic considerations in the use of antiepileptic drugs.
Epilepsia
28(suppl 2): S23 - S29, 1987.
Ater SB, et al. A developmental center population treated with VPA and L-carnitine. In: Update 1993: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals; 1993.
Freeman JM, Vining EP, Cost S, et al. Does carnitine administration improve the symptoms attributed to anticonvulsant medications? A double-blinded, crossover study.
Pediatrics
93: 893 - 895, 1994.
De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia
39: 1216 - 1225, 1998.
Tomita S, Ohnishi J, Nakano M, and Ichikawa Y. The effects of anticonvulsant drugs on vitamin D
3
-activating cytochrome P-450-linked monooxygenase systems.
J Steroid Biochem Mol Biol
39: 479 - 485, 1991.
Hendel J, Dam M, Gram L, et al. The effects of carbamazepine and valproate on folate metabolism in man.
Acta Neurol Scand
69: 226 - 231, 1984.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci
145: 109 - 112, 1997.
Reynolds EH. Mental effects of anticonvulsants, and folic acid metabolism.
Brain
91: 197 - 214, 1968.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc
95: 352 - 356, 1995.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother
29: 726 - 735, 1995.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother
32: 802 - 817, 1998.
Ono H, Sakamoto A, Eguchi T, et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.
Metabolism
46: 959 - 962, 1997.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother
32: 802 - 817, 1998.
Krause K-H, Bonjour J-P, Berlit P, et al. Biotin status of epileptics.
Ann N Y Acad Sci
447: 297 - 313, 1985.
Said HM, Redha R, and Nylander W. Biotin transport in the human intestine: inhibition by anticonvulsant drugs.
Am J Clin Nutr
49: 127 - 131, 1989.
Nau H, Tzimas G, Mondry M, et al. Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapy.
Life Sci
57: 53 - 60, 1995.
Arenz A, Klein M, Fiehe K, et al. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med
62: 548 - 551, 1996.
Mizuno N, Kawakami K, and Morita E. Competitive inhibition between 4'-substituted pyridoxine analogues and pyridoxal for pyridoxal kinase from mouse brain.
J Nutr Sci Vitaminol (Tokyo)
26: 535 - 543, 1980.
Wada K, Ishigaki S, Ueda K, et al. An antivitamin B
6, 4'-methoxypyridoxine, from the seed of
Ginkgo biloba
L.
Chem Pharm Bull (Tokyo)
33: 3555 - 3557, 1985.
Yagi M, Wada K, Sakata M, et al. Studies on the constituents of edible and medicinal plants. IV. Determination of 4-O-methylpyridoxine in serum of the patient with gin-nan food poisoning [in Japanese; English abstract].
Yakugaku Zasshi
113: 596 - 599, 1993.
Arenz A, Klein M, Fiehe K, et al. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med
62: 548 - 551, 1996.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.